Embracing new technology exposes your organization to new risk. KPMG can help turn that risk into opportunity.
Technological developments are revolutionizing patient care, but also raising issues around trust, security, and confidentiality. Discover now life sciences organizations can remain resilient, protect sensitive customer data, and promote accountability in their dealings with customers, patients, suppliers, and regulators.
As the pace of digital continues to accelerate, organizations are expected to make faster decisions and move from ideation to revenue with speed. In the race to harness emerging technologies faster than the competition, organizations are sidestepping the IT function and neglecting governance, which can lead to significant costs, risks and diminished value of IT investment. The process that organizations use to evaluate, select, invest and deploy emerging technologies can lead to competitive differentiation and market growth or monetary loss, write-downs and reputational damage.
Instead of narrowly focusing on the vulnerability and security components of digital transformation, KPMG’s Emerging Technology Risk professionals take a broader, more holistic view of the risk element. We concentrate on the strategic impact that emerging technologies and new business models can have on your entire organization. We help you establish a governance framework that embraces disruptive technologies and encourages innovation while ensuring risks are identified and managed.